Lifecore Biomedical, Inc. Common Stock
LFCRStock
$4.95−36.80%52W
Market Cap$187.93M
P/E—
Div yield—
Beta1.11
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-47.86%
Price vs S&P 500 (4W)-9.76%
VGM Score41.91
Market Capitalization$187.93M
Earnings Surprise History
Q1 26-0.43est. -0.24
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.09
4.09
4.09
4.09
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
LFCRLifecore Biomedical, Inc. Common Stock | C | D | C | $4.95 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Lifecore Biomedical is a fully integrated CDMO providing development, manufacturing, and fill-finish services for complex sterile injectable pharmaceuticals. The company serves multiple delivery formats—syringes, vials, and cartridges—and operates two business segments: contract development and manufacturing services, and hyaluronic acid manufacturing.